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Increased nausea and dizziness when using tramadol
for post-operative patient-controlled analgesia (PCA)
compared with morphine after intraoperative
loading with morphine
K. F. J. Ng, S. L. Tsui, J. C. S. Yang and E. T. F. Ho
Department of Anaesthesiology, The University of Hong Kong, Rm 415, Block K, Queen Mary Hospital, Hong Kong
Summary 4–8, 12–16, 16–20 and 32–36 h). The incidence of diz-
ziness was also significantly higher in group T (68.4%
Thirty-eight ASA I–III patients undergoing lower ab-
vs. 31.6%, group T vs. group M, P < 0.05). There was
dominal operations were randomly allocated to re-
no difference in the overall satisfaction. We concludeceive either morphine (group M, patient-controlled
that the use of tramadol, compared with morphine,analgesia bolus=1 mg of morphine) or tramadol
for post-operative PCA after intraoperative loading(group T, patient-controlled analgesia bolus=10 mg
with morphine is associated with more nausea andof tramadol) for post-operative patient-controlled anal-
dizziness, but with similar sedation, quality of anal-gesia (PCA) after receiving morphine intraoperatively.
gesia and patient satisfaction.There were no between-group differences in the pain,
sedation or vomit scores. The nausea scores were
Keywords: analgesia, patient-controlled, tramadol,significantly higher in group T in the initial 20 h and
between 32 and 36 h (P < 0.01, 0–4 and 8–12 h; P < 0.05, morphine; surgery, lower abdominal.
Introduction committee. All patients gave informed written consent
to participate in the study. Patients <18 years old, of
Tramadol is an effective opioid analgesic. It may be
ASA class IV or above, not mentally fit for the operation
superior to other ‘conventional’ opioids such as mor-
of PCA, who requested other post-operative analgesic
phine and pethidine when used as a post-operative
techniques, with known allergy to morphine or tra-
analgesic because of its relative lack of sedative and
madol, with known history of substance or alcohol
respiratory depressive effects at clinically effective
abuse, and pregnant or lactating women were ex-
doses [1,2]. Intraoperative loading with tramadol, how-
cluded.ever, may be undesirable because of the possibility
There were two treatment groups. All patients re-of awareness associated with its use [3]. We designed
ceived patient-controlled intravenous injection of an-this study to evaluate in a randomized, double-blind
algesics via a Graseby 3300 PCA pump (Grasebymanner the efficacy and side-effect profile of tramadol
Medical Ltd, Watford, UK) for post-operative analgesia.used as an alternative to morphine for post-operative,
In the morphine group (group M), patients had mor-patient-controlled analgesia (PCA) after intraoperative
phine 1 mg mL−1 in 0.9% sodium chloride solution inloading with intravenous morphine.
their pump. In the tramadol group (group T), patients
had tramadol 10 mg mL−1 in 0.9% sodium chloride
Materials and methods solution. The dose ratio of tramadol to morphine of
10:1 was based on previous reports [1,2]. All pumpsThe study was approved by the institutional ethics
were set to an identical setting with a PCA bolus of
1 mL (corresponding with morphine 1 mg in group MAccepted March 1998
Correspondence: K. F. J. Ng. and tramadol 10 mg in group T). No basal infusion
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Table 1. Scoring for nausea, vomit and sedationwas prescribed. The lockout intervals were all set at
5 min. In both groups, patients were prescribed on an
Condition Scoring criteria‘as required’ basis, metoclopramide 10 mg intra-
venously and pethidine 0.4 mg kg−1 intramuscularly
Nausea 0=no nausea
every 4 h as the rescue antiemetic and analgesic re-
1=mild nausea, patient not requesting
spectively. metoclopramide
Eligible patients were allocated randomly to one of 2=nausea, patient requesting
the two treatment groups according to random pick metoclopramide
3=nausea resistant to metoclopramideof sealed envelopes at the end of the operation. Both
the patients and the nurses responsible for post-op- Vomit 0=no vomit
erative care and observation of the patients were 1=mild vomit, patient not requesting
blinded to the grouping of the patients. metoclopramide
2=vomit, patient requestingAll patients were given instructions on the use of
metoclopramidePCA during the preoperative assessment and brought
3=vomit resistant to metoclopramideto theatre with no premedication. General anaesthesia
was induced with thiopentone 4–5 mg kg−1, a single Sedation 0=fully awake
1=slightly drowsybolus dose of 50–100 lg of fentanyl and a loading
2=sleeping but easily arousabledose of atracurium 0.5–0.6 mg kg−1 or vecuronium
3=unconscious, not arousable0.1 mg kg−1. The patients’ tracheas were then in-
tubated and intermittent positive pressure ventilation
started. Anaesthesia was maintained with a mixture
of O2, N2O plus enflurane or isoflurane. Atracurium thereafter. Nausea and vomiting were assessed on
two separate four-point scoring scales and degree ofor vecuronium were used for muscle paralysis by
continuous infusion. All patients received incremental sedation on another four-point scale (Table 1). All
these observations were made every 4 h. In addition,intravenous doses of morphine for intraoperative anal-
gesia. The dose was decided by the attending an- the total number of times the patients activated the
pump (‘tries’), the number of pump activations thataesthetist. Intraoperative use of tramadol was avoided
because of concern over the possibility of an increased actually resulted in drug delivery (‘goods’), the ratio
of these two numbers (‘tries/goods’ ratio) and the totalrisk of awareness [3]. At the end of the procedure, the
study drug was prepared by the attending anaesthetist dose of drug consumed were recorded daily. Use of
rescue analgesic or antiemetic and other symptomsaccording to the instruction in the envelope. The syr-
inges were labelled as ‘study opioid’ and put into such as dizziness, headache, dry mouth and other
discomfort were also recorded daily. An overall assess-patients’ PCA pumps. All nurses in the recovery room
and in the wards were blinded to the type of opioid ment of the analgesic technique as good, fair or un-
satisfactory was given by the patients onused. The patients were then extubated and sent to
the recovery room where PCA was started. discontinuation of the PCA pump. Any major com-
plications, defined as a sedation score of 3, RR < 8 andWhen analgesia was required in the recovery room,
patients would either activate the PCA pumps them- PaCO2 > 6.7 kPa, or patients requiring re-intubation and
ventilatory support or SpO2 < 90% for > 5 min withselves or, if they were still drowsy, the recovery room
nurses would activate the pump for them. Patient optimal O2 therapy by mask were recorded. The
patients were also followed up daily by an anaesthetistobservation, which was carried out by nurses, was
also started in the recovery room and continued in from the pain management team. However, the pain
management team physician was only responsible forthe wards. Vital signs including blood pressure (BP),
pulse (P), oxygen saturation (SpO2) and respiratory the clinical well-being of the patients. They did not
contribute to the entry of any data that would sub-rate (RR) were recorded. Arterial blood gas was
checked if RR < 10 or clinically indicated. Analgesia sequently be analysed in this study. Whenever the
analgesic or the setting on the PCA pump waswas assessed by a verbal rating scale (VRS) from 0 to
10, hourly in the first 24 h after operation, and 4-hourly changed, the patient was be excluded from the study.
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Table 2. Demographic data and operative detailsThe PCA pumps were used by the patients for at least
48 h unless they requested discontinuation before this.
M TThe reason for discontinuation was recorded under
Group (n=19) (n=19)
such circumstances. Refilling of the syringes was done
by one of the investigators to keep the nurses on the
Age (years) 59.26 (18.02) 57.68 (13.90)
wards blinded. If patients still wanted the PCA pump Sex (M/F) 10/9 7/12
after 48 h, they were allowed to continue with PCA. Body weight (kg) 52.57 (9.51) 56.58(10.27)
The sample size of 19 in each group was able to ASAI∗ 7 (37%) 5 (26%)
ASAII 9 (47%) 12 (63%)detect with 80% power an intergroup difference in
ASAIII 3 (16%) 2 (11%)nausea, vomit or sedation score of 1, assuming a
Operation duration (min) 153.68 (51.45) 142.11 (60.99)standard deviation of 1 at an a-error level of 0.05.
Blood loss (mL) 418.82 (457.60) 478.75 (379.95)
Statistical analysis was performed using the soft-
Intraoperative morphine 7.00 (3.09) 7.73 (2.95)
ware programme Statistica release 4.5 (StatSoft, Tulsa, (mg)
OK, USA). Non-parametric data such as nausea and
Values are means (SD).vomit scores, pain score, number of demands on
∗Number (percentage).PCA pump and patient demographic variables were
analysed by Mann–Whitney U-test and chi-squared
test as appropriate. Parametric data were compared
by two-tailed independent t-tests. Significance level
was set at P< 0.05.
Results
A total of 39 patients were studied, 19 in group T and
20 in group M. One patient in group M was excluded
from the study in the early post-operative period be-
cause of complications (detailed below). Limited data
were available from this patient, and he was excluded
from the analysis. Patient demographics, operation
duration, amount of blood loss and the dose of intra-
operative morphine administered are summarized in
Table 2. Fig. 1. Verbal rating scale (VRS) pain scores and sedation
No differences were observed in the 4-hourly pain scores. Values are means±SEM. There were no between-
group differences throughout the study (Mann–Whitneyscores in the two treatment groups throughout the
U-test for between-group comparison).study period (Fig. 1). The average hourly demands
made on the PCA pump, the ratio of total demands to
‘good’ demands (tries/goods ratio) and the number of 36 h after operation (Fig. 2). However, there were no
differences in the vomit scores (Fig. 3). Two patientsrequests for rescue analgesic during the study period
were also not different. These are summarized in required metoclopramide in group M (10.5%) and
seven patients in group T (36.8%). The difference wasTable 3. No patient was excluded from the study
because of inadequate analgesia necessitating not significant (P=0.13, chi-squared test with Yates‘
correction). Significantly more patients in group Tchanges in the PCA regime. The hourly consumption
of morphine was 1.05 mg (0.68–1.41 mg, 95% CI), and (68.4%) experienced some dizziness during the study
period than those in group M (31.6%) (P < 0.05, chi-that of tramadol was 9.79 mg (6.71–12.86 mg, 95% CI)
during the study period. This gives a dose ratio of squared test).
There were no differences in the sedation scoresabout 1:9.3 for intravenous morphine to tramadol.
Patients in group T had significantly higher nausea throughout the study period. The mean sedation
scores are summarized in Fig. 1. Whereas no majorscores in the initial 20 h, as well as between 32 and
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Table 3. Analgesic requirement during the study period
M T
Group (n=19) (n=19) P-value
Hourly demands made 1.89 (1.89) 2.80 (4.55) NS
Tries/goods ratio 0–24 h 2.55 (2.56) 2.85 (2.02) NS
24–48 h 1.61 (0.71) 1.84 (1.30) NS
Request for rescue analgesic∗ None 17 (89%) 17 (89%) NS
Once 1 (5%) 1 (5%)
Twice 0 0
> Twice 1 (5%) 1 (5%)
Values are means (SD).
∗Number (percentage).
Request for rescue analgesic analysed by Mann–Whitney U-test.
Tries/goods ratio and hourly demands analysed by Student’s t-test.
Fig. 2. Four-hourly nausea scores. Values are Fig. 3. Four-hourly vomit scores. Values are means±SEM.
means±SEM. Nausea scores were significantly higher in There were no between-group differences throughout the
group T in the initial 20 h and between 32 and 36 h study (Mann–Whitney U-test for between-group
(Mann–Whitney U-test for between-group comparison). comparison).
complication occurred in the group T patients, two group T. The differences were not significant (P=0.26,
patients in group M became deeply sedated (sedation Mann–Whitney U-test).
score of 3). Both episodes occurred in the initial 4 h
after operation. One of these patients also developed
Discussion
CO2 retention. Intravenous naloxone was administered
to this patient, the setting on the PCA pump was The results of our study demonstrated a similar quality
of analgesia and degree of patient satisfaction usingreduced, and the patient was excluded from the study.
There were no differences in the BP, P, RR and SpO2 tramadol for post-operative PCA when compared with
morphine in a group of patients after lower abdominalbetween the two groups throughout the study.
Eleven patients (57.9%) rated their PCA experience surgery. In the largest study to date comparing intra-
venous tramadol and morphine for post-operativeas good overall, seven (36.8%) as fair and one (5.3%)
as bad in group M. Fifteen (78.9%) patients rated good, analgesia in a non-PCA setting, Vickers et al. [1]. have
also found similar efficacy of the two drugs. A singlethree (15.8%) rated fair and one (5.3%) rated bad in
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intravenous bolus dose of tramadol has also been We considered adequate opioid loading intra-
operatively an essential part of perioperative paindemonstrated to offer comparable analgesia to epi-
management. Patients should have adequate anal-dural morphine after thoracotomy with combined gen-
gesia emerging from anaesthesia. This increasederal and epidural anaesthesia [4]. The use of tramadol
patient comfort in the recovery room and smoothedin PCA has also been compared with PCA pethidine
out the transition to using PCA post-operatively. In our[5] with satisfactory results. There is little doubt that
institution, intravenous morphine is the conventionaltramadol is an effective intravenous analgesic for use
technique for intraoperative analgesia under generalin the post-operative period administered either as a
anaesthesia. We have chosen not to use short-actingbolus or via a PCA pump.
opioids such as alfentanil intraoperatively in our study.Unlike other ‘conventional’ opioids, the mechanism
Unless we allowed our patients to emerge from an-of action of tramadol involves not only the l-receptor,
aesthesia in pain, irrespective of whether we used abut also inhibition of 5-HT and noradrenaline reuptake
short- or long-acting opioid intraoperatively, patientsin the central nervous system [6]. In fact, the analgesic
needed to have residual opioid activity in the initialeffect of tramadol can only be partially reversed by
post-operative period. We decided to use morphinenaloxone [6]. These multiple sites of action may ac-
intraoperatively even for the tramadol group becausecount for the potential benefit of tramadol when used
of the possible association between the intraoperativeas a post-operative analgesic, namely the lower risk
use of tramadol and awareness under general an-of respiratory depression [2]. In the present study,
aesthesia, although the evidence in the literature isone patient receiving morphine developed respiratory
not conclusive [3,8].depression requiring naloxone. Although no stat-
In contrast to previous studies, we were unable toistically significant difference can be demonstrated
demonstrate less patient sedation in the tramadol
regarding the incidence of respiratory depression be-
group. This might be related to the difference in the
tween the two groups, this is most probably because
route of administration, namely by PCA in the present
of the low power of our sample when looking at rare
study. The small sample size may also contribute to
events such as respiratory depression. Bakhshi et al.
this. Another possibility is the residual sedating effect
[7] have demonstrated a lower incidence of de-
of intraoperative morphine, which would mask any
saturation when tramadol is used post-operatively
difference in sedation, at least in the early post-op-
when compared with morphine.
erative period. Any difference in sedation, if present,
Our present study demonstrated an increased in-
should be most obvious in this period.
cidence of dizziness and increased incidence and se- We conclude from our study that tramadol is com-
verity of nausea in patients receiving PCA tramadol parable with morphine when used in post-operative
compared with PCA morphine. The difference in PCA in terms of safety and efficacy following lower
nausea was most marked in the initial 12 h after the abdominal operations. However, the concomitant use
operation. This was not observed in previous studies of intravenous morphine intraoperatively is associated
in which intraoperative morphine had not been used with a more frequent incidence of nausea and diz-
[1,5]. One possible explanation for our observation is ziness. Further investigations are required to over-
that there may be ‘synergism’ between the residual come this problem. For example, the use of
effect of intraoperative morphine and that of sub- prophylactic antiemetics acting via 5-HT3 antagonism
sequently administered tramadol in terms of causing may be useful, given the inhibitory effect of tramadol
nausea and dizziness in the initial post-operative on 5-HT reuptake. At present, it seems prudent to
period. Given the multiple sites of action of tramadol, avoid loading with morphine if tramadol is to be used
it is quite likely that its effect on nausea and vomiting for post-operative analgesia.
is also mediated via receptors other than the opioid
receptor and, therefore, compounded by the con-
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